At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Douglas Easton, PhD, from the University of Cambridge, Cambridge, United Kingdom, provides an overview of the opportunities and challenges associated with applying the knowledge of a patient’s genetic susceptibility for breast cancer in clinical management, including the potential to individualise breast cancer screening options and risk-reduction measures.
Genetically determining susceptibility of breast cancer
14th June 2016
Oncology
Join our mailing list
To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now